Glatiramer acetate
Glatiramer Acetate is a generic prescription drug manufactured by Mylan Pharmaceuticals Inc., approved under ANDA091646. It's an injectable solution (20 mg/mL) administered subcutaneously for treating multiple sclerosis. Packaged as 30 pre-filled syringes (1 mL each) in a carton. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Glatiramer Acetate is a generic prescription drug manufactured by Mylan Pharmaceuticals Inc., approved under ANDA091646. It's an injectable solution (20 mg/mL) administered subcutaneously for treating multiple sclerosis. Packaged as 30 pre-filled syringes (1 mL each) in a carton. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Glatiramer acetate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Glatiramer acetate — ANDA 020622 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020622"
}
]
|
| identifier | ANDA020622 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Glatiramer acetate |
